申请人:RENJI HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE
公开号:US10799495B2
公开(公告)日:2020-10-13
A benzodiazepine alkaloid compound and a pharmaceutically acceptable salt thereof, the structure of the compound being shown in general formula (I).
in the formula (I), R1, R2 and R3 independently are hydrogen, C1-4 alkyl or C1-4 alkanoyl; one from among R4 and R5 is a benzene ring or a substituted benzene ring, while the other is hydrogen, a benzene ring or a substituted benzene ring, wherein a substituent group on the substituted benzene ring is hydroxyl, cyano, amino, halogen, C1-4 alkyl, C1-4 alkoxy, C1-4 alkylamine, C1-4 alkanoyl or C1-4 alkoxyacyl. A method for synthesizing the compound and a use in the preparation of anti-tumor drugs. The compound shown in formula (I) may be used for preparing anti-tumor, especially anti-lung cancer, drugs as well as anti-fungal drugs.
一种苯并二氮杂卓生物碱化合物及其药学上可接受的盐,该化合物的结构如通式 (I) 所示。
式(I)中,R1、R2 和 R3 独立地为氢、C1-4 烷基或 C1-4 烷酰基;R4 和 R5 中的一个为苯环或取代苯环,而另一个为氢、苯环或取代苯环,其中取代苯环上的取代基为羟基、氰基、氨基、卤素、C1-4 烷基、C1-4 烷氧基、C1-4 烷胺、C1-4 烷酰基或 C1-4 烷氧基酰基。一种合成化合物的方法及在制备抗肿瘤药物中的用途。式(I)所示化合物可用于制备抗肿瘤药物,特别是抗肺癌药物以及抗真菌药物。